Figueira José Alejandro Valdevila, Ochoa Alfonso Daniel Silva, Erazo Luz María Valencia, Dutazaka María Gracia Madero, Bigman Galya, Parra Indira Dayana Carvajal
Instituto de Neurociencias de Guayaquil, Guayaquil, Ecuador.
Universidad Ecotec, Samborondón, Ecuador.
Front Nutr. 2025 Sep 5;12:1658703. doi: 10.3389/fnut.2025.1658703. eCollection 2025.
Schizophrenia (SCZ) and other related factors could be associated with specific nutritional problems. Some serum biomarkers could be involved in the clinical presentation of psychotic disorders. These individuals could have significantly lower bone mineral density (BMD) and a higher prevalence of osteoporosis comparatively.
The purpose of our study was to assess the association of key elements of the nutritional status between patients with SCZ and other mental illnesses to promote effective treatment plans.
This was an observational, cross-sectional study with convenience sampling. The sample was divided into two groups: SCZ (S) ( = 66) and no SCZ (NS) ( = 47). We included 113 adults aged from 22 to 85 years admitted to the Institute of Neurosciences of Guayaquil (INC) residency. Anthropometric and body composition indicators were analyzed. Blood samples were collected using appropriate venipuncture techniques, ensuring aseptic conditions and minimizing hemolysis. Wilcoxon rank sum test, two-sample t test, Fisher's exact test, and linear regression were applied to assess variables among groups.
The median BMI was 24.14 kg/m. Visceral fat and serum creatinine were significantly higher in the S group. The prevalence of anemia, low vitamin D, low HDL, high total cholesterol, and low creatinine was 64.60, 68.14, 22.12, 10.62, and 30.97%, respectively. BMI, age, and body fat jointly influenced creatinine ( = 0.03265), while BMI and age were strongly associated with visceral fat ( < 0.001). No significant associations were found between CRP and body fat or BMI.
The nutritional treatment in these patients should aim to prevent and treat anemia, low vitamin D, low HDL, high total cholesterol, low bone mass, and low creatinine serum levels in these groups of patients. Visceral fat and body fat percentage tend to increase with aging and should be monitored carefully. The treatment should be multidisciplinary. More studies are needed to better understand this interplay.
精神分裂症(SCZ)及其他相关因素可能与特定的营养问题有关。一些血清生物标志物可能参与了精神障碍的临床表现。这些个体的骨矿物质密度(BMD)可能显著较低,骨质疏松症的患病率相对较高。
我们研究的目的是评估SCZ患者与其他精神疾病患者营养状况关键要素之间的关联,以制定有效的治疗方案。
这是一项采用便利抽样的观察性横断面研究。样本分为两组:SCZ组(S)(n = 66)和非SCZ组(NS)(n = 47)。我们纳入了113名年龄在22至85岁之间入住瓜亚基尔神经科学研究所(INC)住院部的成年人。分析了人体测量和身体成分指标。使用适当的静脉穿刺技术采集血样,确保无菌条件并尽量减少溶血。应用Wilcoxon秩和检验、两样本t检验、Fisher精确检验和线性回归来评估组间变量。
BMI中位数为24.14kg/m²。S组的内脏脂肪和血清肌酐显著更高。贫血、低维生素D、低高密度脂蛋白(HDL)、高总胆固醇和低肌酐的患病率分别为64.60%、68.14%、22.12%、10.62%和30.97%。BMI、年龄和体脂共同影响肌酐(β = 0.03265),而BMI和年龄与内脏脂肪密切相关(P < 0.001)。未发现CRP与体脂或BMI之间存在显著关联。
这些患者的营养治疗应旨在预防和治疗这些患者群体中的贫血、低维生素D、低HDL、高总胆固醇、低骨量和低血清肌酐水平。内脏脂肪和体脂百分比往往随年龄增长而增加,应仔细监测。治疗应是多学科的。需要更多研究来更好地理解这种相互作用。